Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Wave Life Sciences (WVE) Revenue: 2015-2025

Historic Revenue for Wave Life Sciences (WVE) over the last 7 years, with Jun 2025 value amounting to $8.7 million.

  • Wave Life Sciences' Revenue fell 55.82% to $8.7 million in Q2 2025 from the same period last year, while for Jun 2025 it was $50.1 million, marking a year-over-year decrease of 54.66%. This contributed to the annual value of $108.3 million for FY2024, which is 4.42% down from last year.
  • Per Wave Life Sciences' latest filing, its Revenue stood at $8.7 million for Q2 2025, which was down 5.19% from $9.2 million recorded in Q1 2025.
  • In the past 5 years, Wave Life Sciences' Revenue ranged from a high of $49.2 million in Q3 2023 and a low of $285,000 during Q3 2022.
  • Moreover, its 3-year median value for Revenue was $16.3 million (2023), whereas its average is $20.4 million.
  • In the last 5 years, Wave Life Sciences' Revenue crashed by 99.22% in 2022 and then surged by 17,168.07% in 2023.
  • Over the past 5 years, Wave Life Sciences' Revenue (Quarterly) stood at $1.8 million in 2021, then dropped by 29.80% to $1.2 million in 2022, then skyrocketed by 2,245.12% to $29.1 million in 2023, then dropped by 10.92% to $19.7 million in 2024, then crashed by 55.82% to $8.7 million in 2025.
  • Its Revenue stands at $8.7 million for Q2 2025, versus $9.2 million for Q1 2025 and $19.7 million for Q2 2024.